| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/21/1999 | EP0513054B1 Virus/herbicide resistance genes process for producing same and their use |
| 04/21/1999 | CN1214738A Immuno-magnetic cell separation used in identification of genes associated with site-preferenced cancer methastasis formation |
| 04/21/1999 | CN1214736A Promoter from tobacco |
| 04/21/1999 | CN1214735A IgA nephropathy-associated gene |
| 04/21/1999 | CN1214734A SCF analog compositions and method |
| 04/21/1999 | CN1214733A Down-regualtion resistant C3 convertase |
| 04/21/1999 | CN1214732A Novel 'beta'-l-4N-acetylglucosaminyltransferase and gene encoding the same |
| 04/21/1999 | CN1214731A Alkaline protease deficient filamentous fungi |
| 04/21/1999 | CN1214695A ErdB3 antibodies |
| 04/21/1999 | CN1214694A Peptides with antiproliferative properties |
| 04/21/1999 | CN1214692A Tumor rejection antigens presented by HLA-B44 molecules and uses thereof |
| 04/21/1999 | CN1214689A Method of producing IGF-I and IGFBP-3 with correct folding and disulfide bonding |
| 04/21/1999 | CN1214366A Method for producing optically active compound |
| 04/21/1999 | CN1214195A Disease resistant plant including thionin gene |
| 04/21/1999 | CA2248169A1 Dnag |
| 04/20/1999 | US5895833 Gene expression compatible with mammary glands |
| 04/20/1999 | US5895813 Diagnosis and treatment of TKA-1 related disorders |
| 04/20/1999 | US5895759 Vector for gene transfer in liver cells |
| 04/20/1999 | US5895756 Non-antibiotic system for selection of recombinant mycobacteria |
| 04/20/1999 | US5895755 Platelet derived growth factor |
| 04/20/1999 | US5895754 Cdna coding for soluble polypeptide with deletion of cytoplasmic and/or transmembrane domain; for screening assays of suppressors of osteoclast function and bone reabsorption |
| 04/20/1999 | US5895747 Screening molecules which suppress activator enhancement of transcription factors containing basic region/leucine zipper domains binding to dna; anticarcinogenic agents; viricides |
| 04/20/1999 | US5895646 Having specific activity in the human bone marrow assay |
| 04/20/1999 | CA2133649C Oral infection of insect larvae with pre-occluded baculovirus particles |
| 04/20/1999 | CA1340506C Production of gonorrheal pi proteins and vaccines |
| 04/20/1999 | CA1340505C Bovine placental lactogen |
| 04/15/1999 | WO1999018516A1 Control of nucleic acid amplification procedures including the polymerase chain reaction (pcr) |
| 04/15/1999 | WO1999018441A1 Icam-4 and diagnostic uses thereof |
| 04/15/1999 | WO1999018242A1 Sensors for electrically sensing binding events for supported molecular receptors |
| 04/15/1999 | WO1999018241A1 Multiple displacement amplification |
| 04/15/1999 | WO1999018239A1 Antimicrobial drug screening using a recombinant cell comprising a rna-dependent amidotransferase gene |
| 04/15/1999 | WO1999018238A1 Combinatorial antisense library |
| 04/15/1999 | WO1999018234A2 Means for qualitative and quantitative analysis of microbial populations potentially present in a sample |
| 04/15/1999 | WO1999018228A2 Method for microbial production of amino acids of the aspartate and/or glutamate family and agents which can be used in said method |
| 04/15/1999 | WO1999018227A1 Chimeric parvovirus-based recombinant vector system that specifically targets the erythroid lineage |
| 04/15/1999 | WO1999018226A2 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 04/15/1999 | WO1999018225A1 Expression of cholera toxin b subunit in transgenic plants and efficacy thereof in oral vaccines |
| 04/15/1999 | WO1999018224A1 Plant fatty acid hydroxylase genes |
| 04/15/1999 | WO1999018223A1 A process for obtaining transgenic leguminous plants (leguminosae) containing exogenous dna |
| 04/15/1999 | WO1999018222A1 Use of beta recombinase in eukaryotic cells, especially for transgenic work |
| 04/15/1999 | WO1999018221A1 Method for introducing and expressing rna in animal cells |
| 04/15/1999 | WO1999018220A1 Papilloma virus capsomere vaccine formulations and methods of use |
| 04/15/1999 | WO1999018219A1 A keratinocyte derived protease |
| 04/15/1999 | WO1999018218A1 Alkaline protease |
| 04/15/1999 | WO1999018217A1 Method for producing branched fatty acids using genetically modified plants |
| 04/15/1999 | WO1999018216A2 Chimeric vaccine against tick-borne encephalitis virus |
| 04/15/1999 | WO1999018215A1 Avian infectious herpesvirus recombinants and recombinant vaccines prepared with the use of the same |
| 04/15/1999 | WO1999018214A1 Porcine circoviruses, vaccines and diagnostic reagents |
| 04/15/1999 | WO1999018213A1 MUTANTS OF YEAST Cdc24p, DEFECTIVE IN BINDING OF THE G-PROTEIN BETA SUBUNIT |
| 04/15/1999 | WO1999018212A1 Natural human antibody |
| 04/15/1999 | WO1999018211A1 Yeast cells expressing modified g proteins and methods of use therefor |
| 04/15/1999 | WO1999018210A2 Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer |
| 04/15/1999 | WO1999018209A1 A HUMAN 2-19 PROTEIN HOMOLOGUE, z219a |
| 04/15/1999 | WO1999018208A1 101 human secreted proteins |
| 04/15/1999 | WO1999018207A1 Human hox c10 and polynucleotides encoding |
| 04/15/1999 | WO1999018206A2 Human cancer antigen ny eso-1/cag-3 and gene encoding same |
| 04/15/1999 | WO1999018205A1 POLYPEPTIDE, cDNA ENCODING THE SAME, AND USE OF THEM |
| 04/15/1999 | WO1999018204A2 HUMAN PROTEINS HAVING SECRETORY SIGNAL SEQUENCES AND cDNAS ENCODING THESE PROTEINS |
| 04/15/1999 | WO1999018203A2 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND cDNAs ENCODING THESE PROTEINS |
| 04/15/1999 | WO1999018202A2 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND cDNAs ENCODING THESE PROTEINS |
| 04/15/1999 | WO1999018201A1 Gankyrin |
| 04/15/1999 | WO1999018200A1 PROTEINS ALIKE TO HUMAN COMPLEMENT FACTOR H AND cDNAs ENCODING THESE PROTEINS |
| 04/15/1999 | WO1999018199A2 cDNAs CODING FOR HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS |
| 04/15/1999 | WO1999018198A1 Hepatitis c receptor protein cd81 |
| 04/15/1999 | WO1999018197A2 Nucleic acid molecule encoding a (poly)peptide co-segregating in mutated form with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (apeced) |
| 04/15/1999 | WO1999018196A1 Methods of refolding proteins by use of zwitterionic low molecular weight agents |
| 04/15/1999 | WO1999018195A2 Methods and compositions for inducing tumor-specific cytotoxicity |
| 04/15/1999 | WO1999018194A1 GENE DELETED RECOMBINANT FeLV PROVIRAL DNA FOR PRODUCTION OF VACCINES AGAINST FeLV |
| 04/15/1999 | WO1999018193A1 Jnk3 modulators and methods of use |
| 04/15/1999 | WO1999018191A1 Transgenic animals with knocked-in vec receptor genes and uses thereof |
| 04/15/1999 | WO1999018190A1 Animal model for fatty acid transport |
| 04/15/1999 | WO1999018187A1 NOVEL clpL |
| 04/15/1999 | WO1999018129A1 Soluble single-chain t-cell receptor proteins |
| 04/15/1999 | WO1999018128A1 Fibroblast growth factor with hepatocyte proliferation activity |
| 04/15/1999 | WO1999018127A1 Secreted proteins and polynucleotides encoding them |
| 04/15/1999 | WO1999018126A1 POLYPEPTIDE, cDNA ENCODING THE POLYPEPTIDE, AND USE OF THE BOTH |
| 04/15/1999 | WO1999018125A1 Human facilitative glucose transport protein glut8 |
| 04/15/1999 | WO1999018122A1 Ama |
| 04/15/1999 | WO1999018117A1 3-hydroxyacyl-coa dehydrogenase from staphylococcus aureus |
| 04/15/1999 | WO1999018116A1 Method for modulating gene expression |
| 04/15/1999 | WO1999017881A1 Apparatus for a fluid impingement thermal cycler |
| 04/15/1999 | WO1999017806A1 Conjugates of galactose-binding lectins and clostridial neurotoxins as analgesics |
| 04/15/1999 | WO1999017800A1 Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions |
| 04/15/1999 | WO1999017798A1 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 04/15/1999 | WO1999017797A1 Use of growth differenciation factor-9 (gdf-9) as a contraceptive |
| 04/15/1999 | WO1999017796A2 Modulation of lerk-2-mediated cell adhesion |
| 04/15/1999 | WO1999017795A1 RIBOSOME RECYCLING FACTOR (FRR) OF $i(STAPHYLOCOCCUS AUREUS) |
| 04/15/1999 | WO1999017794A1 UDP-N-ACETYLMURAMOYL-L-AIANINE:D-GLUTAMATE LIGASE (murD) OF STAPHYLOCOCCUS AUREUS |
| 04/15/1999 | WO1999017791A1 Methods and compositions for reducing bacterial tolerance of disinfectants and organic solvents |
| 04/15/1999 | WO1999017741A1 Chlamydia protein, gene sequence and uses thereof |
| 04/15/1999 | WO1999017610A1 Protein delivery by secretory gland expression |
| 04/15/1999 | WO1999011818A8 Method for detecting highly functional polypeptides or nucleic acids |
| 04/15/1999 | WO1999011778B1 Antisense treatment of pulmonary hypertension |
| 04/15/1999 | WO1999009210A3 Mutation within the connexin 26 gene responsible for prelingual non-syndromic deafness and method of detection |
| 04/15/1999 | WO1999009180A3 Method for enzymatically producing guanosine diphosphate-6-desoxyhexoses and the use thereof for producing oligosaccharides |
| 04/15/1999 | WO1999009054A3 Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders |
| 04/15/1999 | WO1999007854A3 Serine/threonine kinase, and uses related thereto |
| 04/15/1999 | WO1999007849A3 Human reticulocalbin isoforms |
| 04/15/1999 | WO1999007738A3 Human orphan receptor ntr-1 |
| 04/15/1999 | WO1999005313A3 Method for typing of minor histocompatibility antigen ha-1 |